Lack of correlation between “in vitro” and “in vivo” antithrombotic activity of heparin fractions and related compounds. Heparan sulfate as an antithrombotic agent “in vivo”
- 1 December 1985
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 40 (5) , 597-607
- https://doi.org/10.1016/0049-3848(85)90298-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Heterogeneity of heparin lots associated with thrombocytopenia and thromboembolismThe American Journal of Medicine, 1984
- Heterogeneity of heparin: characterization of one hundred components with different anticoagulant activities by a combination of electrophoretic and affinity chromatography methodsInternational Journal of Biological Macromolecules, 1981
- The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studiesBiochemical Journal, 1981
- Isolation and pharmacological activities of heparin and other sulfated mucopolysaccharides from thymusBiochemical Pharmacology, 1981
- Failure of aspirin at different doses to modify experimental thrombosis in ratsThrombosis Research, 1980
- Experimental model of venous thrombosis in rats and effect of some agentsThrombosis Research, 1980
- Anticoagulant Activities of High and Low Molecular Weight Heparin FractionsBritish Journal of Haematology, 1979
- Heparin: new concepts relevant to clinical useBlood, 1979
- Evaluation of an amidolytic heparin assay method: Increased sensitivity by adding purified antithrombin IIIThrombosis Research, 1977
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin TimeNew England Journal of Medicine, 1972